To be fair, this isn't an accurate characterisation. ACR's "farm" is more like its IP, its human capital and its lab. The royalties are the fruits of its farm. So bringing these royalties forward by selling them, may be quite reasonable. That is, as long as it got an adequate price for them.
- Forums
- ASX - By Stock
- ACR
- Ann: Gedeon Richter buyout Lenzetto Royalties for EUR4.1million
Ann: Gedeon Richter buyout Lenzetto Royalties for EUR4.1million, page-14
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.79M |
Open | High | Low | Value | Volume |
4.4¢ | 4.4¢ | 4.4¢ | $820 | 18.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 93384 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 93384 | 0.044 |
2 | 547000 | 0.043 |
2 | 94414 | 0.041 |
3 | 322500 | 0.040 |
1 | 120000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 10000 | 1 |
0.047 | 24318 | 1 |
0.048 | 44500 | 3 |
0.049 | 120000 | 1 |
0.052 | 103000 | 2 |
Last trade - 10.00am 18/11/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online